240: Continuous Microbial Manufacturing: From Genetic Instability to 40-Day E. coli Processes with Juergen Mairhofer - Part 2

Why do CDMOs keep building bigger stainless-steel facilities while their margins erode and Asian competitors undercut them on price? And what happens when big pharma decides to stop outsourcing altogether? The business model that sustained the industry for two decades is under pressure from every direction, and for many CDMOs, standing still is no longer a neutral position.

In Part 2, Juergen Mairhofer, CEO of enGenes Biotech, shifts from the science to the stakes. Having spent over a decade building a company on licensing proprietary microbial technology rather than selling fermentation capacity, he brings a distinctive vantage point on where the CDMO industry is headed and what it will take to stay relevant.

Here are some of the topics discussed:

• The need for innovation to stay competitive against lower-cost regions, and why capacity-focused business models are running out of road (03:08)
• How continuous manufacturing creates a competitive edge for CDMOs operating in high-cost regions (05:49)
• Practical advice for piloting continuous processing, building partnerships, and taking calculated risks before competitors do (06:36)
• The parallel universe of batch and continuous manufacturing, and how this duality will shape the industry over the next decade (08:24)
• What scientists need to know before spinning out a technology company: customer focus, cash discipline, and why the team is everything (09:49)
• Big pharma's return to in-house manufacturing and vertical supply chain integration, and why this creates opportunity for innovation-focused partners (12:12)

Smart insight: Technology excellence is necessary but not sufficient. Juergen's closing word was simply "don't be afraid" and it carried weight precisely because it was not a platitude. The companies that will matter in ten years are those that start the hard work of innovation now, before the window closes.

If you’re interested in exploring more breakthroughs in continuous bioprocessing and the future of biotech manufacturing, check out these past episodes from the Smart Biotech Scientist Podcast:

• Episodes 85 - 86: Bioprocess 4.0: Integrated Continuous Biomanufacturing with Massimo Morbidelli
• Episodes 153 - 154: The Future of Bioprocessing: Industry 4.0, Digital Twins, and Continuous Manufacturing Strategies with Tiago Matos
• Episode 155: From Process Bottlenecks to Seamless Production: How Continuous Bioprocessing Changes Everything
• Episode 156: The Hidden Economics of Continuous Processing That Most Biotech Companies Overlook
• Episodes 181 - 182: Innovating Continuous Bioprocessing with Vibrating Membrane Filtration with Jarno Robin
• Episodes 209 - 210: From Batch to Continuous: Building Innovation Culture in Conservative Biotech Environments with Irina Ramos

Connect with Juergen Mairhofer:

LinkedIn: www.linkedin.com/in/juergen-mairhofer-ab27a5b

enGenes Biotech GmbH website: www.engenes.cc

Next step:

Need fast CMC guidance? → Get rapid CMC decision support here

Support the show